Optimizing the endoscopic diagnosis of mediastinal lymphadenopathy: a glimpse on cryobiopsy

Michele Mondoni1, Giovanni Sotgiu2

  • 1Respiratory Unit, ASST Santi Paolo E Carlo, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Via A. Di Rudinì n.8, 20142, Milan, Italy. michele.mondoni@asst-santipaolocarlo.it.

BMC Pulmonary Medicine
|September 19, 2022
PubMed

Insights

Mediastinal cryobiopsy, a novel bronchoscopic technique, offers larger tissue samples for diagnosing mediastinal lymphadenopathy, potentially improving molecular assessments and complementing traditional methods like EBUS-TBNA.

Area of Science:

  • Pulmonology
  • Interventional Pulmonology
  • Diagnostic Imaging

Background:

  • Mediastinal lymphadenopathy diagnosis is challenging, with endosonography (EBUS-TBNA) being standard but sometimes yielding insufficient tissue for molecular analysis.
  • Cryobiopsy, successful in interstitial lung disease diagnosis, provides larger tissue samples and is being explored for mediastinal lymph nodes.

Discussion:

  • A recent study explored ultrasound-guided transbronchial cryobiopsy after EBUS-TBNA for mediastinal lymphadenopathy in suspected malignancies.
  • The potential added value of mediastinal cryobiopsy for histopathological and molecular assessment in malignancies was discussed.

Key Insights:

  • EBUS-cryobiopsy shows promise for diagnosing mediastinal lymphadenitis, offering larger tissue yields than conventional methods.
  • Cryobiopsy may enhance histopathological and molecular assessments, crucial for advanced lung cancer and other lymph node disorders.

Outlook:

  • Mediastinal cryobiopsy requires further research to clarify its learning curve, optimal strategies, diagnostic accuracy, and safety.
  • This technique is likely complementary to conventional endosonography, with rapid on-site evaluation guiding its use.

Related Concept Videos